Table 2.
Characteristics of 445 ovarian cancer patients
| Clinical Factor | N Cases (%) |
|---|---|
| Recurrence status | |
| Recurred or deceased | 275 (62%) |
| No recurrence | 170 (38%) |
| Histologic Sub-type | |
| Serous | 289(66%) |
| Mucinous | 19 (4%) |
| Endometrioid | 74(17%) |
| Clear cell | 29 (7%) |
| Mixed epithelial | 27 (6%) |
| Age at diagnosis, yrs | |
| <50 | 78(18%) |
| 50-59 | 114 (26%) |
| 60-69 | 119(27%) |
| 70+ | 134 (30%) |
| Stage | |
| I | 85(19%) |
| II | 32 (7%) |
| III | 251 (56%) |
| IV | 77(17%) |
| Grade | |
| 1-2 | 70(16%) |
| 3 | 207 (48%) |
| 4 | 151 (35%) |
| Tumor volume following surgery | |
| Optimal, <_ 1 cm remaining | 363 (85%) |
| Suboptimal, >_ 1 cm remaining | 65(15%) |
| Ascites | |
| Yes | 215 (63%) |
| No | 125 (37%) |
| Chemotherapy | |
| Yes | 404 (91%) |
| No/Unknown | 41 (9%) |
| Chemotherapeutic Agent | |
| Platinum and taxane | 353 (91%) |
| Platinum only | 17 (4%) |
| Taxane only | 4 (1%) |
| Neither platinum or taxane | 12 (3%) |
Numbers may not add to 445 due to missing data; key demographic and clinical factors shown.